Pipeline

NTN-101 is a gadolinium based contrast agent (GBCA), attached to an immunologically inert nanopartic

NTN-101 is a gadolinium based contrast agent (GBCA), attached to an immunologically inert nanoparticle, designed to remain within the vascular system

As a result NTN-101 provides

1.  Superior Signal Enhancement -- Ultra high MRI definition of blood vessels with relaxivity of 134 vs 4 to 28 for other GBCAs

2. Longer useful plasma time Viable Image time – 90 to 120 minutes versus 4 to 36 minutes with other GBCAs

3. Non-renal elimination – provides a more safe alternative to patients with renal insufficiency. NTN-101 is cleared through the liver

4. Lower doses requirement – due the the greater signal strength, lower doses of NTN-101 are required thus increasing the safety margins

image1